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B lymphocytes appear in peripheral blood and 
secondary lymphoid organs after they have dif-
ferentiated from precursor B cells in bone mar-
row (1) and have created a unique B cell antigen 
receptor by V(D)J rearrangement of their Ig 
heavy and Ig light chain loci (2). In the periph-
ery, multiple B cell subsets can be identifi  ed, 
which are either naive or have been exposed 
to antigen.
The mouse spleen has been extensively 
studied for B cell maturation (for review see 
reference 3). Although several models exist (4, 5), 
the general consensus is that recent bone mar-
row emigrants are AA4.1+ and defi  ned as tran-
sitional B cells. Subsequently, these cells can 
give rise to either naive follicular B cells, or 
marginal zone (MZ) B cells, which are named 
based on their anatomical location. MZ B cells 
show a rapid and predominantly T cell–indepen-
dent response to pathogens, whereas follicular B 
cells show a T cell–dependent response in a 
germinal center reaction, where they undergo 
somatic hypermutation (SHM) and class-switch 
recombination (CSR) to generate an optimized 
high affi   nity antibody response.
In man, the recent bone marrow emi-
grants, i.e., the transitional B lymphocytes, are 
CD38+CD24+IgD+ and are relatively small sub-
set compared with the CD38−IgM+IgD+CD27− 
naive mature B lymphocytes in blood and rep-
resent a peripheral lymphoid organs (6, 7). 
In peripheral blood, a substantial fraction of 
the naive B lymphocyte population expresses 
the CD5 antigen and is prone to produce poly-
reactive antibodies (8). Splenic MZ B lym-
phocytes in man are IgM+IgD+CD27+. They 
show a rapid IgM response to blood-borne 
T cell–independent antigens (9, 10) and their 
Ig loci carry somatic mutations (11). Counter-
parts of splenic MZ B lymphocytes are found 
in lymph nodes, tonsils, and Peyer’s patches, 
and they circulate in blood (12–15). Because 
these cells are not anatomically located in the 
splenic MZ, it was suggested to refer to them as 
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natural eff  ector B lymphocytes (16). T cell–dependent re-
sponsive B lymphocytes proliferate in a germinal center 
  re  action as centroblasts (CD38+CD77+IgD−) (for review see 
reference 17). These centroblasts undergo SHM before fur-
ther diff  erentiation into centrocytes (CD38+CD77−IgD−), 
which are subsequently selected based on the highest affi   nity 
for their cognate antigen, undergo CSR, and give rise to ei-
ther CD27+ memory B lymphocytes or CD38hi antibody–
producing plasma cells (18). B cell   proliferation upon antigen 
encounter in the germinal center is a key step in the humoral 
immune response, which has been extensively studied (19, 20), 
but the extent of   antigen-induced proliferation of B lym-
phocytes remains largely unknown.
Recent reports suggest that in addition to antigen-induced 
proliferation, naive B lymphocytes can proliferate without 
further diff  erentiation (21–23). This homeostatic prolifera-
tion of naive B lymphocytes has been described in mouse 
models in response to a B cell defi  cit (22). Theoretically, the 
absolute number of naive B lymphocytes is regulated by four 
processes: (a) output from bone marrow; (b) survival; (c) loss 
of naive B lymphocytes via further maturation after anti-
gen encounter (24); and (d) antigen-independent (homeostatic) 
Figure 1.  Detection of coding joints and signal joints of kappa-
deleting rearrangements in mice (A) and man (B). V(D)J recom-
bination on the IGK locus results in a Vκ-Jκ coding joint. Subsequent 
rearrangement between the IRS1 (mouse) or intronRSS (human) and the 
RS (mouse) and Kde (human) elements can make the IGK allele nonfunc-
tional by deleting the Cκ exons and the enhancers. Consequently, the 
coding joint precludes any further rearrangements in the IGK locus and 
therefore remains present in the genome. The KREC with the corresponding 
signal joint is a stable double-stranded, circular DNA structure. The coding 
joint in the genome and the signal joint on the episomal excision circle 
can be quantifi  ed via RQ-PCR using the indicated primers and TaqMan 
probes. The murine IGK locus contains two intronRSS sequences, IRS1 and 
IRS2, of which IRS1 has the most conserved RSS sequence and is >10-fold 
more frequently found in rearrangements to RS (reference 62 and 
unpublished data).JEM VOL. 204, March 19, 2007  647
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proliferation. However, similar to the extent of antigen-induced 
B cell proliferation, it remains unclear to what extent prolif-
eration contributes to naive B lymphocyte numbers; to answer 
both questions, a robust assay is needed to assess the replica-
tion history of B cells.
Here we introduce the use of kappa-deleting recombina-
tion excision circles (KRECs) to determine the replication 
history of both human and mouse mature B cell subsets. 
  Rearrangement of the Jκ-Cκ intron recombination signal 
  sequence (IRS1 in mouse and intronRSS in man) to the 
kappa-deleting element (RS in mouse and Kde in man) ren-
ders the IGK locus nonfunctional, precludes any further rear-
rangements in the IGK locus, and therefore the coding joint 
of this rearrangement remains stably present in the genome 
(Fig. 1, A and B) (25, 26). It is a common rearrangement be-
cause it is present in  30% of Igκ+ and in almost all Igλ+ 
mature human B lymphocytes and does not infl  uence antigen-
specifi  city (27, 28). The chromosomal DNA located in between 
the two rearranging elements is excised from the genome and 
circularized into stable episomal structures, which are diluted 
twofold by each cell division (Fig. 2 A) (29–32). Previously, 
we demonstrated the use of T cell receptor excision circles 
(TRECs) for studying rearrangement and proliferation pro-
cesses (30, 31). Subsequently, TRECs of δREC-ψJα rear-
rangements have been used as markers for recent thymic 
emigrants and T cell expansion in patients treated for HIV 
infection (33–35).
In this study, we introduce the use of KRECs to accu-
rately assess the replication history of isolated mouse and 
human B cell subsets. Using this approach we demonstrate 
homeostatic proliferation of mature B lymphocytes, but not 
of transitional B lymphocytes, in healthy individuals. Fur-
thermore, mouse MZ and human natural eff  ector B lympho-
cytes, which mainly respond to T cell–independent antigens, 
undergo additional antigen-induced proliferation. The T cell–
dependent antigen response in the germinal center was 
found to be much stronger with regard to both proliferation 
and SHM.
RESULTS
The KREC assay is a robust technique to determine 
the replication history of B cells
The ratio between the kappa-deleting rearrangement and the 
corresponding excision circle can be used as measure for the 
in vivo replication history of an isolated B cell subset, assum-
ing that the excision circle is a stable DNA structure, which 
is diluted twofold in every cell division (Fig. 2 A). Conse-
quently, real-time quantitative (RQ)-PCR assays were de-
signed for detection of the coding joints and the corresponding 
signal joints of both the mouse IRS1–RS (Fig. 1 A) and 
the human intronRSS–Kde (Fig. 1 B) rearrangements. The 
two mouse RQ-PCR assays were tested for equal effi   ciency 
on serial dilutions of constructs containing either the cod-
ing joint or the signal joint. To minimize the chance of 
Figure 2.  Quantifi  cation of the replication history of B cells using 
KRECs. (A) When a B lymphocyte with an intronRSS–Kde rearrangement 
divides, both daughter cells inherit the intronRSS–Kde coding joint in the 
genome. However, the signal joint, which is on the episomal KREC, will be 
inherited by only one of the two daughter cells. Crucially, the ∆CT of the 
PCRs detecting the coding joint and the signal joint exactly represent the 
number of cell divisions a B lymphocyte has undergone because both 
processes have an exponential increase with base number 2. (B) The ∆CT 
between the coding joint and the signal joint is shown for mouse splenic 
B cells that were cultured in vitro with polyclonal stimulation and were 
sorted based on the CFSE staining intensity as measure for 0, 1, 2, 3, and 
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  contamination in potential future clinical studies, a special 
cell line control was created for the human KREC studies. 
The Igκ+ B cell line U698-M was selected because it has two 
Vκ-Jκ–rearranged IGK alleles, one of which is out-of-frame 
and contains an intronRSS–Kde rearrangement (Fig. 3, A 
and B). To obtain an equal ratio between the intronRSS–
Kde coding and signal joints, an intronRSS–Kde signal joint 
construct was inserted into the genome of the U698-M cell 
line using retroviral transduction. Individual clones were 
sorted, and Southern blot analysis revealed a single insertion 
per genome for three clones: DB01, DB11, and DE09 
(Fig. 3 B). Each of these stable B cell lines contained both 
the coding joint and the corresponding signal joint of the 
intronRSS–Kde rearrangement and were therefore used as 
positive control for assessment of the effi   ciency of both 
human RQ-PCR assays.
The stability and twofold dilution of excision circles were 
investigated by in vitro proliferation experiments. Resting B 
lymphocytes were isolated from wild-type mouse spleen, la-
beled with CFSE, and cultured with IL-4, LPS, and anti-IgM 
for 2–3 d. DNA was isolated from B cells before culture and 
from sorted B cells that had undergone 1, 2, 3, or 4 cell divi-
sions to quantify the kappa-deleting rearrangement and the 
excision circle. The combined data from three individual experi-
ments show that resting B lymphocytes contain a coding joint 
to signal joint ratio of  1:1 (∆CT = 0). Furthermore, the 
∆CT (CTcoding joint – CTsignal joint) of the RQ-PCRs corresponded 
well with the number of cell divisions these cells underwent 
in culture as observed with CFSE staining (Fig. 2 B). There-
fore, the KREC assay can be used as a robust technique to 
determine the replication history of B cell subsets in vitro.
In vivo replication history of mouse B cell subsets
To determine the in vivo replication history using the KREC 
assay in a well-defi   ned system, mouse B cell subsets 
(B220+) from spleen and Peyer’s patches were isolated 
(Fig. 4 A). From spleen, T1 (AA4.1+CD23−) and T2 
(AA4.1+CD23+) transitional B cells and naive follicular 
(AA4.1−CD21lowCD23hi) and MZ (AA4.1−CD21hiCD23low) 
B lymphocytes were purifi  ed, whereas IgA+ class-switched 
B lymphocytes were isolated from Peyer’s patches. Total 
bone marrow samples were used to determine the replication 
history of precursor B cells, in which the Igκ-deleting rear-
rangement is initiated (Fig. 4 A).
Precursor B cells in bone marrow and transitional B cells 
in spleen did not show replication (Fig. 4 B). In contrast, na-
ive follicular B cells showed limited proliferation (1 cell divi-
sion). MZ B cells and class-switched IgA+ B cells showed a 
more extensive replication history of 4 and 5.5 cell divisions, 
respectively. As expected, the observed replication histories 
increased with more progressive diff  erentiation stages. Con-
sequently, the KREC assay is a powerful tool to study not 
only the in vitro replication history but also the in vivo repli-
cation history of sorted B cell subsets.
The extent of antigen-induced B cell proliferation in man
The majority of the intronRSS–Kde rearrangements in man 
is initiated in small pre–B-II cells (27). Therefore, B cell sub-
sets starting with the small pre–B-II stage were isolated from 
bone marrow, tonsil, and peripheral blood using previously 
established markers (Fig. 5 A and Fig. 6 A) (6, 15, 18, 27, 36) 
to quantify intronRSS–Kde coding joints in the genome and 
the intronRSS–Kde signal joints on the KRECs. The cod-
ing joints were easily detected; 35–50% of the alleles in all 
peripheral B cell subsets carried this rearrangement (not 
depicted). In small pre–B-II and immature B cells the ∆CT was 
0.4 (Fig. 5 B). This indicates that precursor B cells in human 
bone marrow hardly proliferate after rearrangement of in-
tronRSS to Kde.
Transitional B lymphocytes in tonsil did not show repli-
cation, whereas naive B lymphocytes in tonsil showed a rep-
lication history of 2.5 cell divisions (Fig. 5 B), indicating 
a substantial proliferation in this subset. Natural eff  ector B 
lymphocytes (counterparts of splenic MZ B lymphocytes) 
underwent more proliferation: on average 4.1 cell divisions. 
Centroblasts and centrocytes in the germinal center, memory 
B cells, and plasma cells all showed a replication history of  8 
cell divisions. As expected by their nature, the centroblasts in 
human tonsil form the major proliferative subset. It can thus 
be concluded that naive mature B lymphocytes have already 
proliferated but massive proliferation is found in subsequent 
germinal center reactions where each cell generates 45 (2[8–2.5]) 
or more daughter cells.
Several mature B lymphocyte subsets circulate in blood 
and can be identifi  ed as counterparts of subsets found in sec-
ondary lymphoid organs (Fig. 6 A). The four main human B 
lymphocyte subsets were isolated from blood of healthy 
adults and analyzed for their replication history. Naive CD5− B 
Figure 3.  Generation of a human control B cell line with one 
  intronRSS–Kde coding joint and one artifi  cially introduced signal 
joint per genome. (A) Schematic representation of the Southern blot 
probes that recognize the IGK alleles of the U698-M cell line and the 
KREC signal joint construct that was introduced into the cell line. The 
Kde probe recognizes both IGK alleles, whereas the Kde-RSS probe recog-
nizes allele 1, which does not harbor an intronRSS–Kde rearrangement, 
and the KREC construct. (B) Southern blot of the original U698-M cell 
line and three single clones that contain a unique insertion of the signal 
joint construct.JEM VOL. 204, March 19, 2007  649
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lymphocytes in adult peripheral blood were found to have a 
replication history of 1.9 (Fig. 6 B), which is almost similar 
to the total bulk of naive mature B lymphocytes in tonsils 
from children. Furthermore, natural eff  ector B lymphocytes 
and memory B lymphocytes in adult blood were found 
to have a replication history of 5.6 and 10.9 cell divisions, 
respectively. For both populations, these numbers are higher 
than what was found in childhood tonsil. This indicates that 
most memory B lymphocytes in adults have been exposed to 
their cognate antigen multiple times and have accordingly 
undergone additional proliferation in consecutive germinal 
center reactions.
The fourth major population isolated from blood was the 
CD5+ naive B lymphocyte subset. This subset had a replica-
tion history of 0.4, similar to small pre–B-II cells and imma-
ture B cells in bone marrow and transitional B lymphocytes 
in tonsil. Thus, contrary to CD5− naive mature B lympho-
cytes, CD5+ naive B lymphocytes do not proliferate in the 
peripheral B cell compartment.
Naive B lymphocytes undergo homeostatic proliferation 
in healthy individuals
Using the KREC assay, we found that the mature B lympho-
cyte subsets, except for the CD5+ naive B lymphocytes, had 
undergone proliferation in the periphery. Antigen-induced 
proliferation is usually accompanied by the induction of SHM. 
To provide a quantitative measurement for the presence of 
SHM, we determined the presence of mutations in a hot-
spot motif in rearranged IGK (Vκ-Jκ) alleles involving the 
Vκ3-20 gene segment using a modifi  ed version of the Igκ re-
striction enzyme-based hot-spot mutation assay (IgκREHMA; 
Fig. 7, A–C) (37).
Neither transitional and naive mature B lymphocytes 
from tonsil, nor CD5+ and CD5− naive B lymphocytes 
from blood carried mutated Vκ3-20 to Jκ rearrangements 
(<1.5%; Fig. 7, D and E). In contrast, germinal center and 
memory B lymphocyte subsets contained substantial num-
bers of mutated Vκ3-20 alleles. Of the rearranged Vκ3-20 
alleles, 7.5% was mutated in natural eff  ector B lymphocytes 
Figure 4.  Replication history of mouse B cell subsets. (A) Scheme 
of the differentiation stages of mature B cell development in mice. B cell 
subsets were isolated based on the indicated marker expression from 
spleen and Peyer’s patches. (B) The replication history of each B cell 
subset. The ∆CT between the coding joint and the signal joint PCRs 
  represents the number of cell divisions, which are given for each subset. 
The data are the means of three independent sorts and are presented as 
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from childhood tonsil, and 16% in natural eff  ector B lym-
phocytes from adult blood. Centroblasts and centrocytes 
from childhood tonsil showed 9% and 12% mutated rear-
ranged Vκ3-20 alleles, respectively. Memory B lymphocytes 
from childhood tonsil had 24% mutated alleles, and memory 
B lymphocytes from adult blood had 30% mutated alleles. 
Finally, plasma cells in childhood tonsil showed 14% mu-
tated alleles.
It can thus be concluded that naive mature B lympho-
cytes in blood and tonsil undergo limited proliferation in 
the absence of SHM, indicative of antigen-independent 
homeostatic proliferation. In contrast, the proliferation of 
centroblasts in tonsil is associated with SHM. The frequency 
of mutated alleles was higher in centrocytes, memory B 
cells, and plasma cells, probably as the result of selection for 
antigen binding. Finally, the frequency of mutated alleles is 
higher in adult natural eff  ector B lymphocytes and memory 
B lymphocytes than in their counterparts isolated from ton-
sils of children. This correlated with the higher proliferation 
rate, fi   tting with additional antigen-induced proliferation 
and SHM in adults.
DISCUSSION
In this study, we demonstrate the contribution of prolifera-
tion to B cell homeostasis and the extent of antigen-induced 
B cell expansion in mouse and man. Assessment of the rep-
lication history and the SHM status allowed us to dis-
criminate homeostatic proliferation from antigen-induced 
proliferation. The homeostatic proliferation in naive B 
lymphocytes did not diff  er between human childhood and 
adult naive B lymphocytes, whereas the extensive prolifera-
tion and SHM of natural eff  ector and memory B cells in adults 
was greater than in children, indicating additional antigen 
encounters in adults.
In our novel RQ-PCR–based KREC assay, we use the 
coding joint versus signal joint ratio of the intronRSS–Kde 
rearrangement to obtain highly accurate quantifi  cation of the 
replication history of mature B lymphocytes. This approach 
diff  ers from studies in which the kinetics of the peripheral B 
cell pool was assessed with BrdU or 6,6-2H2-glucose (38, 39). 
The latter studies have provided insight into the recent turn-
over of B cell subsets but could not quantify the contribution 
of proliferation to B cell homeostasis. Because of time-lapse 
Figure 5.  Replication history of human B lymphocyte subsets 
from childhood tonsil. (A) Scheme of the differentiation stages 
of mature B cell development. The B cell subsets that contain the 
  intronRSS–Kde rearrangement were isolated from bone marrow and 
tonsil samples of young children using the indicated markers. 
(B) The replication history of each B cell subset. The ∆CT between the 
coding joint and the signal joint PCRs, which represents the number of 
cell divisions is given for each subset. The data are the means of inde-
pendently sorted subsets from three children and are presented as 
mean ± SD.JEM VOL. 204, March 19, 2007  651
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  diff  erences (measurement 3–4 d after deuterium glucose 
  infusion) it was not possible to determine whether proliferation 
occurred in the investigated B cell diff  erentiation stage or in 
an earlier (preceding) diff  erentiation stage (39). The KREC 
assay allows us to assess the total number of cell divisions that 
B cells, in a well-defi  ned subset isolated from lymphoid tis-
sue, have undergone since their emigration from bone marrow. 
Consequently, diff  erences in replication history between 
B cell subsets can be straightforwardly assessed by measuring 
the KREC content of the B cell subsets under study.
The applicability of KRECs depends on their stability, 
which has been suggested before (29) but never formally 
proven. In theory, the excision circles can be subject to tran-
scriptional activity and recombinase activity in precursor 
B cells because of the presence of IGK enhancers. Further-
more, it is unclear whether excision circles remain stably present 
in the nucleus of one of the two daughter cells after cell divi-
sion. We show here that there is very little or no breakdown 
of KRECs in precursor B cells and that the KREC content is 
diluted twofold with every cell division.
The use of KRECs to measure the replication history of 
B cell subsets is analogous to the use of δREC–ψJα rear-
rangements and their corresponding TRECs to study T cell 
dynamics. Although the use of TRECs provided insight into 
the eff  ects of novel antiviral therapies on the thymic output 
in patients with HIV infection (33, 34), TRECs could not be 
used to quantify proliferation because most δREC–ψJα cod-
ing joints are deleted from the genome by subsequent Vα–Jα 
rearrangements (30, 31). Therefore, TREC data as measured 
in T lymphocytes of healthy and diseased individuals are dif-
fi  cult to interpret (31, 35). Our KREC assay does not have 
these limitations. In contrast, the intronRSS–Kde rearrange-
ment has several advantages for studying the replication his-
tory of B lymphocytes: (a) it is a frequently occurring IGK 
gene rearrangement in both normal and malignant B cells 
(27, 28); (b) it is one of the last Ig gene rearrangements in 
bone marrow–derived B cells before obtaining a functional 
Ig molecule (27), ensuring that the corresponding KRECs 
are abundantly present in naive B lymphocytes; (c) it is a 
single-step rearrangement, which allows easy design of RQ-
PCR primers and probes for accurate detection of the coding 
joints and signal joints (40); and (d) it is an end-stage rear-
rangement, precluding further rearrangements (41), which 
implies that the coding joint is retained in the genome while 
the corresponding signal joint on the KREC is diluted two-
fold by each cell division. These characteristics make the 
intronRSS–Kde rearrangement a solid RQ-PCR target for 
accurate quantifi  cation of mature B lymphocyte proliferation.
The intronRSS–Kde rearrangement is initiated in precur-
sor B cells in bone marrow and is frequently found to inacti-
vate functionally rearranged IGK loci, suggesting actively 
induced receptor editing in bone marrow (42). Furthermore, 
receptor revision has been speculated to occur in peripheral 
B lymphocytes, based on low levels of RAG gene transcrip-
tion and the presence of double-stranded DNA breaks in Jκ 
gene segments (43–48). If intronRSS–Kde rearrangements 
would be induced in the process of receptor revision in pe-
ripheral B lymphocytes, the observed number of cell divi-
sions measured with KRECs should be an underestimate. 
However, because the RAG mRNA and double-stranded 
DNA break levels are clearly lower in peripheral B cell subsets 
compared with bone marrow and RAG expression is inhib-
ited by BCR signaling (49, 50), the infl  uence of receptor revi-
sion on measuring proliferation using KRECs will be limited.
The contribution of proliferation to B lymphocyte ho-
meostasis in healthy individuals has never been shown. Using 
the KREC assay we were able to address this issue. We found 
no replication history for transitional B lymphocytes in mouse 
spleen and childhood tonsil. In addition, no replication was 
seen in the CD5+ B cell subset in human peripheral blood. 
Recently, it has been shown that nearly all human transi-
tional B cells express CD5, whereas only a fraction of the 
naive mature B lymphocytes express CD5 (7). Thus, the 
CD5+ B lymphocyte subset we isolated from peripheral blood 
Figure 6.  Replication history of the four main B lymphocyte sub-
sets in adult peripheral blood. (A) Schematic overview of the four main 
blood B lymphocyte subsets and the markers that were used to isolate 
them from adult peripheral blood. (B) The replication history of these 
subsets was determined as the ∆CT of the coding joint and the signal joint 
PCR of subsets isolated from four or fi  ve donor samples (represented as 
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mainly consists of transitional B lymphocytes. Consequently, 
the limited proliferation seen in CD5+ B lymphocytes is 
likely to be caused by the high abundance of excision circles 
from transitional B lymphocytes. Therefore, it remains un-
clear whether the absence of proliferation in the CD5+ B cell 
subset refl  ects a diff  erence in maturation stage or is a direct 
eff  ect of CD5 expression.
Naive follicular B lymphocytes in mice and naive ma-
ture B lymphocytes obtained from human blood and tonsil 
showed proliferation in the absence of SHM. By defi  nition, 
this is homeostatic proliferation, which occurred in the periph-
ery, because no replication history was found for precursor 
B cells and transitional B lymphocytes. Homeostatic prolif-
eration has been observed before in naive T and NK cells 
(51–54). It has been suggested to occur in B lymphocytes also 
(23), but it was only observed in response to a B cell defi  cit 
(21, 22). Our results show for the fi  rst time that homeo-
static proliferation of naive mature B lymphocytes occurs in 
healthy individuals and contributes greatly to the homeostasis 
of absolute B lymphocyte numbers by two- to fourfold 
  expansion of the naive B lymphocyte pool. The factors 
  driving this homeostatic proliferation need to be identifi  ed in 
future studies.
Splenic MZ B lymphocytes in mice showed more repli-
cations than naive follicular B lymphocytes. In absence of 
B cell infl  ux from bone marrow, MZ B lymphocytes persist 
much longer than naive follicular B lymphocytes (55). Our 
results support earlier suggestions that this persistence partly 
results from an increased proliferation capacity. It remains un-
clear, however, whether this proliferation is antigen induced, 
especially because these cells carry nonmutated Ig genes (10). 
In contrast, human MZ B lymphocytes have a memory phe-
notype (CD27+) and carry mutated Ig genes generated mainly 
in response to T cell–independent antigens (9, 10, 15). We 
found that the replication history of their counterparts in 
childhood tonsil, natural eff  ector B lymphocytes, was com-
parable to that of mouse MZ B lymphocytes. Studies in 
children younger than 2 yr suggest that natural   eff  ector 
B lymphocytes undergo SHM during ontogeny (15). This 
observation supports the idea that similar to mouse human 
Figure 7.  Quantifi  cation of SHM in human B cell subsets. The 
IgκREHMA assay was modifi  ed from Andersen et al. (37) for use on 
genomice DNA. (A) Schematic representation of a Vκ3-20 to Jκ rear-
rangement on genomic DNA. The Vκ3-20 gene segment contains two 
Fnu4HI restriction sites in a SHM hot-spot in the CDR1 region. In addi-
tion, a KpnI site is located downstream of the Fnu4HI sites in the FR2 
region. Vκ3-20–Jκ rearrangements were PCR amplifi  ed with one HEX-
labeled Vκ3-20–intron forward and two Jκ reverse primers that recog-
nize all fi  ve Jκ gene segments (61). Digestion of these PCR products 
with both Fnu4HI and KpnI resulted in unmutated fragments of 244 
and 247 bp and mutated fragments of 262 bp. (B and C) Spectratyping 
of Vκ3-20–Jκ rearrangements of CD5+ B lymphocytes and memory 
B lymphocytes after double digest with Fnu4HI and KpnI. CD5+ 
B lymphocytes did not have a replication history and showed no SHM, 
whereas memory B lymphocytes in adult blood had undergone 
11 cell cycles in the periphery and showed 30% mutated Vκ3-20–Jκ 
rearrangements. (D and E) The percentage of mutated Vκ3-20–Jκ 
rearrangements was measured in the same DNA samples that were 
previously used for determining the replication history (data represent 
means ± SD).JEM VOL. 204, March 19, 2007  653
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MZ B lymphocytes are generated independent of antigen. 
However, in this study we observed increased proliferation 
and SHM in natural eff  ector B lymphocytes from adult blood 
compared with childhood tonsil, consistent with antigen-
  induced maturation. Consequently, more insight into the induc-
tion of SHM is needed to solve the question whether MZ B 
lymphocytes and natural eff  ector B lymphocytes in man are 
generated dependently or independently of antigen.
The T cell–dependent response of B lymphocytes in a 
germinal center reaction is thought to be more powerful than 
the T cell–independent response. Our analyses indeed con-
sistently showed that the germinal center response was greater 
with regard to proliferation and SHM. Interestingly, the rep-
lication history of germinal center–derived B cells diff  ered 
greatly among mice, children, and adults. A plausible expla-
nation is the exposure to antigen. Mice that are 5–12 wk old 
and kept under specifi  c pathogen-free conditions are exposed 
to a limited load and spectrum of antigens and likely have less 
extensive B cell maturation. Furthermore, the increased pro-
liferation of memory B lymphocytes from adults compared 
with children correlated with increased frequencies of mu-
tated IGK alleles. This could refl  ect additional maturation re-
sulting from secondary and tertiary immune responses to a 
specifi  c antigen, or additional activation over time induced 
by innate stimuli acting on innate antigen receptors, such as 
Toll-like receptors (56).
In this study, we introduced the robust KREC assay to 
quantify the replication history of mouse and human B lym-
phocyte subsets in vivo. We observed similar trends in both 
species. In combination with the IgκREHMA assay to de-
termine SHM, this resulted in new and quantitative insights 
into homeostatic proliferation of naive mature B lymphocytes 
and the extent of the humoral immune response in healthy 
individuals. Importantly, the techniques and insights demon-
strated in this study provide a fi  rm basis for clinical evaluation 
of the regeneration of the peripheral B cell compartment 
  after hematopoietic stem cell transplantation or B cell–directed 
antibody therapy. Furthermore, these new insights will contri-
bute to the understanding of defects in homeostatic or antigen-
induced B cell proliferation in patients suff  ering from common 
variable immunodefi  ciency or another antibody defi  ciency.
MATERIALS AND METHODS
Mice, B cell culture, and B cell subset isolation. The animal studies were 
approved by the Institutional Animal Care and Use Committees of the Erasmus 
University Rotterdam and the University of California, San Diego.
Resting B cells were purifi   ed from total splenocytes of young adult 
C57BL/6 mice (5–12 wk) using the MACS B cell isolation kit (Miltenyi 
Biotec), labeled for 10 min at 37°C with 7.5 μM CFSE, and cultured for 
2–3 d in RPMI medium containing 10% fetal calf serum, 200 U/ml penicillin, 
200 μg/ml streptomycin, 4 mM l-glutamine, and 50 μM β-mercaptoethanol 
supplemented with IL-4, anti-IgM, and LPS at 1 ng/ml.
B cell subsets were purifi  ed from spleen and Peyer’s patches using a 
FACSAria cell sorter (BD Biosciences). The following monoclonal antibodies 
were used: CD21-FITC (7G6), CD23-PE (B3B4), B220-PerCP (RA3-6B2), 
IgM-biotin (II/41), IgA-biotin (C10-1; all from BD Biosciences), AA4.1-APC, 
streptavidin PE-cy7, IgM-APC (II/41; all from eBiosciences), and IgD-PE 
(11–26; Southern Biotechnology Associates, Inc.).
Isolation of (precursor) B cell subsets from human bone marrow, 
peripheral blood, and tonsil. All bone marrow, peripheral blood, and 
tonsil samples were obtained with informed consent and according to the 
guidelines of the Medical Ethics Committee of Erasmus MC. 
Precursor B cells were obtained from freshly isolated bone marrow sam-
ples of three healthy children (age 3–16) as described previously (27).
Four B cell subsets were purifi  ed from blood samples of fi  ve healthy 
adults using a FACSDiVa cell sorter (BD Biosciences) after staining of 
post-Ficoll mononuclear cells that were MACS sorted using CD19 beads 
(Miltenyi Biotec) with CD27-FITC (LT27; Serotec), IgD-PE, CD19-
PE-Cy7 (SJ25C1), and CD5-APC (L17F12; all from BD Biosciences).
Seven tonsillar B lymphocyte subsets were sorted from tonsils of three 
children on a FACSDiVa cells sorter after direct staining on freeze-thawed 
material (17). Additional monoclonal antibodies used were CD77-FITC 
(5B5) and CD38-APC (HB7; both from BD Biosciences).
All fractions were obtained with a purity of >95%.
Generation of control constructs and control cell line for the KREC 
assay. Mouse kappa-deleting coding and signal joints were PCR amplifi  ed 
from total bone marrow and cloned into the pGEMT-easy vector (Promega). 
Effi   ciency was tested on dilution series of the construct. A pGEMT-easy 
RQ-PCR was performed to correct for input.
A human KREC signal joint was PCR amplifi  ed in two parts from 
bone marrow mononuclear cell DNA to introduce an EcoRI restriction site 
60 bp upstream of the Kde RSS heptamer sequence, and subsequently 
cloned into the retroviral LZRS-IRES-eGFP vector (Fig. 3 A). The LZRS-
KREC construct was transfected into the Phoenix amphotropic packaging 
cell lines using Fugene-6 (Roche Molecular Biochemicals). Stable high-
titer producer clones were selected with puromycin (1 μg/ml). The U698-
M pre–B cell line was cultured for several days in RPMI 1640 medium 
containing 10% FCS and antibiotics before transduction using Retronectin-
coated Petri dishes (Takara) and recombinant retrovirus containing su-
pernatant for 2 d, with daily replenishing of retroviral supernatant. 
GFP-positive cells were single cell sorted using a FACSDiVa cell sorter. 
Individual clones were selected for dim GFP expression, suggesting a single 
genomic integration.
Southern blot analysis of individual U698-M KREC cell line clones. 
DNA isolation and Southern blot analysis was performed as previously 
described (57). The confi  guration of the IGK locus was determined using 
32P-labeled probes: the IGK-Kde probe is specifi  c for the Kde region (58), 
and the Kde-RSS probe is specifi  c for the region upstream of Kde, which 
is deleted from the genome after an intronRSS–Kde rearrangement and are 
present on the KREC construct (Fig. 3 B).
RQ-PCR and calculation of the replication history of B cell 
populations. Primers and probes were designed to specifi  cally amplify 
the IRS1-RS and intronRSS–Kde rearrangements (coding joint) and 
the corresponding signal joint using TaqMan-based RQ-PCR from DNA 
isolated from cell lines and primary material (Fig. 1, A and B). The RQ-
PCR mixture of 25 μl contained TaqMan Universal MasterMix (Applied 
Biosystems), 900 nM of each primer, 100 nM of each FAM-TAMRA–
  labeled probe, 50 ng of DNA, and 0.4 ng BSA, and was run on the 
ABIPRISM 7700 sequence detection system (Applied Biosystems) (59, 60). 
The primer-probe sets were tested for comparable effi   ciencies using dilu-
tion series of plasmid constructs (for mouse reagents), and DNA was iso-
lated from the U698-M clones DB01, DB11, and DE09, which contain one 
intronRSS–Kde rearrangement and one KREC construct per genome (for 
human reagents).
In all experiments, the cycle threshold (CT) was set at 0.03, and the 
Ct values of the coding joint and the signal joint were compared for each 
sample. Because both PCR amplifi  cation and cell division are exponential 
multiplication processes with base 2, the ∆CT (CTintronRSS–Kde – CTKREC) 
from a given cell fraction represents the mean number of cell divisions 
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SHM analysis using a V𝗋3-20–specifi  c restriction enzyme hot-spot 
mutation assay (Ig𝗋REHMA) on genomic DNA. To investigate the 
occurrence of SHM in specifi  c B cell subsets, we modifi  ed the IgκREHMA 
assay developed by Andersen et al. (37) for use on genomic DNA (Fig. 7 A). 
In short, a PCR reaction was performed using a HEX-coupled Vκ3-20 intron 
forward primer and two FAM-coupled Jκ reverse primers recognizing all 
fi  ve Jκ gene segments (61). The PCR products ( 500 bp) were digested 
with KpnI and Fnu4HI and run on a Capillary Sequencer ABI 3100 (Applied 
Biosystems). The Fnu4HI restriction enzyme recognizes two adjacent sites 
in the unmutated gene product in the SHM hot-spot region of CDR1. 
  Unmutated gene products can therefore be visualized as 244 or 247-bp 
HEX-coupled fragments. KpnI cuts the gene products in FR2 downstream 
of the Fnu4HI sites, resulting in a 262-bp HEX-coupled mutated fragment. 
The unmutated B cell line CLL-1 was used as a positive control for complete 
digestion with Fnu4HI. The digests hardly contained undigested gene pro-
ducts of  481 bp, indicating complete digestion by KpnI.
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